cell
death
play
crucial
role
myriad
physiolog
process
sever
human
diseas
cancer
character
deregul
mani
method
avail
quantifi
qualifi
accur
process
cell
death
occur
choos
right
assay
tool
essenti
gener
meaning
data
provid
suffici
inform
clinic
applic
understand
cell
death
process
vitro
cell
death
assay
import
step
search
new
therapi
cancer
ultim
goal
remain
elabor
drug
interfer
specif
cell
death
mechan
howev
choos
cell
viabil
cytotox
assay
among
mani
avail
option
daunt
task
inde
cell
death
approach
sever
viewpoint
requir
holist
approach
review
provid
overview
cell
death
assay
usual
use
vitro
assess
cell
death
elabor
new
potenti
chemotherapeut
discuss
consider
use
assay
resist
death
major
characterist
cancer
cell
henc
emerg
consider
interest
develop
therapeut
strategi
could
interfer
cellular
death
decis
cell
death
play
major
role
homeostasi
tissu
allow
elimin
transform
cell
deregul
cell
death
cancer
impli
effect
drug
kill
cell
outright
inhibit
growth
provid
complet
clinic
respons
besid
resist
cell
death
tumorigenesi
may
also
explain
tumor
relaps
follow
chemotherapeut
treatment
thu
cell
deathrel
assay
primari
import
field
oncolog
drug
discoveri
obvious
cell
death
unequivoc
occur
mani
option
beyond
semant
reason
abil
distinguish
form
cell
death
also
clinic
relev
develop
specif
therapeut
drug
suitabl
everi
cell
death
process
inde
respons
anticanc
therapi
modul
certain
form
cell
death
specif
modal
cell
death
identifi
drug
discoveri
assay
consequ
differ
vitro
method
identifi
dead
cell
cell
cultur
describ
includ
detect
endstag
cell
death
irrespect
type
well
process
associ
particular
subroutin
cell
death
apoptosi
also
refer
program
cell
death
consid
appropri
indic
cell
death
categori
cell
death
pathway
includ
necrosi
autophag
cell
death
anoiki
interest
matter
fact
recent
classif
defin
differ
form
cell
death
may
involv
variou
molecular
signal
pathway
research
describ
least
pathway
cell
death
exist
apoptot
cell
frequent
undergo
secondari
necrosi
vitro
condit
appear
apoptosi
necrosi
may
repres
extrem
type
cell
death
wide
rang
cell
death
mode
therefor
might
difficult
distinguish
specif
death
condit
monolith
differ
may
distinct
appear
furthermor
appropri
cell
death
assay
must
rigor
select
experiment
set
investig
choos
right
assay
tool
appropri
end
point
measur
cell
death
condit
sine
qua
non
gener
meaning
data
remain
challeng
task
inde
cell
death
approach
varieti
viewpoint
includ
measur
dead
cell
cytotox
assay
quantif
live
cell
viabil
assay
ultim
determin
accur
mechan
involv
therefor
plethora
strategi
monitor
cell
death
requir
select
choic
best
suit
cell
death
assay
accord
studi
aim
singl
method
may
suffici
determin
type
cell
death
review
provid
overview
cell
death
assay
current
use
vitro
estim
cell
death
assess
journal
cell
death
new
potenti
chemotherapeut
discuss
in
out
scientif
approach
cell
death
typic
occur
necrosi
apoptosi
autophagi
concern
apoptosi
character
impli
sever
criteria
chang
nuclear
morpholog
especi
chromatin
fragment
condens
also
occurr
apoptot
bodi
contain
nuclear
materi
well
reduct
cell
volum
plasma
membran
shrinkag
intrins
extrins
stimuli
lead
apoptosi
differ
pathway
involv
specif
biochem
manifest
activ
caspas
caspas
caspas
classic
activ
intracellular
pathway
process
mitochondri
outer
membran
permeabil
momp
wherea
extracellular
pathway
requir
activ
caspas
howev
cell
type
includ
hepatocyt
pancreat
cell
activ
caspas
describ
momp
process
lead
galluzzi
et
al
underlin
extrins
apoptosi
activ
extracellular
stress
signal
character
death
receptor
induc
caspas
signal
cascad
involv
caspas
caspas
caspas
caspas
display
central
role
apoptot
mechan
famili
protein
also
involv
smac
small
mitochondrialderiv
activ
caspas
iap
inhibitor
apoptosi
protein
famili
death
receptor
famili
also
play
central
role
apoptosi
machineri
cell
surfac
receptor
activ
specif
death
ligand
entir
process
highli
regul
lead
ultim
massiv
cell
destruct
without
inflammatori
respons
contrast
immunogen
cell
death
form
cell
death
also
refer
immunogen
apoptosi
induc
effect
antitumor
respons
activ
cell
dendrit
cell
potenti
immunogen
cell
death
induc
character
includ
chemotherapi
well
radiotherapi
cell
death
variant
defin
exposur
calreticulin
calr
membran
releas
protein
includ
member
heat
shock
protein
famili
parallel
necrot
cell
exhibit
common
trait
comparison
apoptot
cell
notabl
cellular
chang
includ
chromatin
condens
apoptot
bodi
observ
necrot
cell
stimul
inflammatori
respons
releas
intracellular
materi
extracellular
milieu
long
time
necrosi
regard
uncontrol
cell
death
process
discoveri
potenti
signal
compon
rip
receptorinteract
protein
kinas
led
concept
program
necrosi
also
call
necroptosi
regul
form
necrosi
requir
catalyt
activ
receptorinteract
protein
kinas
regard
autophagi
major
control
catabol
mechan
tightli
regul
autophagyrel
gene
autophag
cell
death
involv
format
doubl
membran
contain
vacuol
sequestr
cytoplasm
subsequ
digest
fusion
lysosom
vacuol
howev
specif
role
autophagi
execut
cell
death
remain
controversi
fulli
elucid
yet
autophagi
may
constitut
epiphenomenon
cell
death
could
analyz
ultim
unsuccess
attempt
cell
cope
stress
reestablish
homeostasi
moreov
concern
recent
neolog
introduc
defin
put
cell
death
modal
truli
reflect
cell
death
pathway
biochem
morpholog
distinct
apoptosi
necrosi
inde
term
mitot
catastroph
anoiki
pyroptosi
often
refer
cell
death
mechan
execut
molecular
machineri
apoptosi
necrosi
contrast
ferroptosi
irondepend
form
cell
death
morpholog
biochem
genet
differ
apoptosi
necrosi
autophagi
particular
form
nonapoptot
cell
death
occur
specif
patholog
condit
activ
oncogen
rasselect
lethal
small
molecul
erastin
iron
depend
final
even
apoptosi
autophagi
necrosi
display
distinct
morpholog
characterist
physiolog
process
share
signific
common
particularli
coordin
matter
fact
condit
apoptosi
autophagi
display
synerget
effect
wherea
autophagi
activ
apoptosi
suppress
consequ
seem
exist
sever
pathway
cell
death
complex
relationship
modal
requir
use
differ
protocol
measur
identifi
type
cell
death
quantit
qualit
analysi
move
away
monolith
point
view
necessari
interrel
cell
death
process
appear
complex
initi
anticip
assess
new
potenti
chemotherapeut
drug
screen
involv
cell
viabil
cytotox
assay
identifi
defin
safeti
threshold
subsequ
clinic
use
assay
reli
sever
cell
function
includ
enzym
activ
cell
membran
activ
cell
adher
adenosin
triphosph
atp
product
coenzym
product
nucleotid
uptak
activ
compound
interfer
cellular
attach
caus
dramat
morpholog
chang
affect
cell
growth
rate
lead
reduct
overal
viabil
consid
cytotox
howev
cytotox
reflect
cellkil
properti
chemic
compound
associ
specif
cell
death
pathway
cell
viabil
defin
number
healthi
cell
sampl
without
distinct
cell
activ
divid
quiescent
one
wherea
cell
prolifer
measur
et
al
number
cell
divid
cultur
viabil
assay
aim
measur
cellular
mainten
surviv
paramet
therebi
myriad
assay
design
use
measur
viabil
cytotox
vitro
includ
particular
classic
dye
inclus
exclus
coloni
format
assay
vital
dye
fluoresc
color
molecul
distinguish
live
dead
cell
provid
conclus
test
assess
cell
death
vitro
vital
dye
frequent
use
includ
exclus
dye
cross
intact
plasma
membran
propidium
iodid
instanc
thu
label
dead
cell
dye
exclus
assay
trypan
blue
wide
use
routin
laboratori
work
bluestain
cell
dead
cell
percentag
viabl
cell
calcul
ratio
viabl
total
number
enumer
cell
hemocytomet
classic
light
microscop
commonli
use
cell
count
cytofluorometri
routin
use
costain
protocol
fluoresc
microscopi
facilit
identif
dead
cell
visual
inspect
contrast
dye
calcein
acetoxymethyl
ester
calceinam
use
select
label
live
cell
thank
lipophil
properti
allow
penetr
easili
cell
subsequ
hydrolyz
intracellular
esteras
gener
fluoresc
plasmamembraneimperm
product
retain
exclus
live
cell
permeabl
assay
remain
quick
inexpens
method
assess
cell
death
provid
robust
artifactfre
inform
unabl
discrimin
differ
cell
mode
furthermor
concern
dye
lipophil
properti
enzymat
activ
intracellular
esteras
may
affect
cell
deathunrel
phenomena
anoth
disadvantag
permeabl
assay
concern
issu
cell
death
intact
membran
cytotox
agent
intracellular
thu
could
underestim
cellular
damag
concern
coloni
format
assay
base
number
cell
form
coloni
vitro
cell
seed
low
densiti
number
coloni
count
growth
period
clonogen
assay
constitut
reliabl
method
assess
cell
viabil
howev
tend
becom
harder
timeconsum
experi
impli
sever
sampl
also
use
assess
cell
prolifer
despit
fact
measur
dna
synthesi
often
prefer
studi
prolifer
easier
inde
method
involv
label
dna
precursor
introduc
cell
measur
dna
incorpor
incub
occurr
cell
divis
vitro
associ
dna
incorpor
proport
relationship
one
reliabl
method
studi
cell
death
measur
leakag
cellular
compon
compromis
cultur
cell
membran
integr
alter
especi
measur
intracellular
protein
often
enzym
cell
cultur
supernat
presenc
biomark
activ
typic
proof
posit
presenc
cytotox
henc
frequent
use
assay
drug
discoveri
experi
instanc
lactat
dehydrogenas
ldh
long
use
marker
cell
death
vitro
model
ldh
releas
broken
cell
membran
cell
death
kit
fluorometr
colorimetr
detect
ldh
commerci
avail
adenyl
kinas
dehydrogenas
cellular
enzym
also
use
cell
death
marker
even
loss
activ
occur
cell
death
assay
unlik
ldh
cell
death
assay
base
ldh
activ
effect
enzymebas
cell
death
assay
lactat
dehydrogenas
activ
indirectli
measur
subject
sampl
coupl
enzymat
chemistri
reagent
contain
lactat
oxid
nicotinamid
adenin
dinucleotid
diaphoras
appropri
redox
dye
resazurin
produc
either
chang
absorb
shift
fluoresc
profil
method
improv
significantli
easier
assay
describ
allow
samewel
measur
ldh
without
need
sampl
simplifi
assay
suitabl
highthroughput
screen
ht
protocol
routin
use
inexpens
easili
implement
plate
howev
major
inconveni
techniqu
physicochem
factor
variat
cultur
medium
ie
ph
may
affect
activ
enzym
subsequ
enzym
activ
may
declin
time
extracellular
milieu
besid
unabl
discrimin
differ
cell
death
mode
detect
may
aggrav
morpholog
chang
die
cell
adenosin
triphosph
produc
live
cell
sine
qua
non
condit
cellular
life
cell
death
process
potenti
synthes
atp
decreas
wherea
endogen
cytoplasm
adenosin
triphosphatas
remov
remain
atp
therefor
cell
viabil
measur
count
atp
amount
cultur
cell
valid
marker
viabl
cell
certain
experiment
condit
sensit
quantif
intracellular
atp
achiev
luciferasebas
assay
amen
ht
studi
base
abil
firefli
luciferas
gener
luminesc
signal
hall
et
al
develop
mutant
form
luciferas
stabl
environment
extrem
well
homogen
reagent
measur
atp
directli
cultur
cell
luminesc
atp
detect
provid
mani
advantag
becom
techniqu
choic
measur
cell
viabil
ht
laboratori
easi
non
timeconsum
wherea
test
compound
interfer
fluoresc
assay
method
moreov
atp
assay
sensit
micropl
assay
avail
detect
viabl
cell
cultur
less
cell
per
well
label
howev
recogn
decreas
intracellular
atp
concentr
may
result
nonleth
perturb
includ
cessat
prolifer
senesc
contact
inhibit
instanc
inhibit
mitochondri
respir
thu
measur
atp
alway
directli
link
cell
viabil
altern
measur
metabol
activ
achiev
use
tetrazolium
salt
dead
cell
metabol
substanc
incub
viabl
cell
tetrazolium
salt
lead
product
color
formazan
product
associ
metabol
activ
subsequ
colorimetr
assay
mtt
xtt
use
measur
cell
surviv
unfortun
similar
atpbas
assay
sever
factor
may
inhibit
mitochondri
reductas
consequ
product
color
formazan
product
may
provid
unequivoc
data
cell
viabil
final
atpbas
mttbase
assay
highli
suscept
metabol
interfer
may
gener
falseposit
result
result
must
valid
secondari
time
cell
death
marker
metabolismori
test
remain
use
get
preliminari
inform
identifi
cell
death
mode
discrimin
cytotox
antiprolif
effect
apoptosi
assay
caspas
activ
membran
alter
dna
fragment
mitochondri
chang
broad
rang
chemotherapi
work
interf
mechan
cell
death
induc
apoptosi
remain
promis
strategi
cancer
drug
discoveri
use
apoptosi
end
point
underli
sever
novel
approach
cell
death
assay
apoptosi
involv
caspas
activ
cleavag
cellular
protein
substrat
cleavag
dna
size
fragment
format
apoptot
bodi
therefor
characterist
repres
potenti
target
novel
specif
drug
despit
fact
caspas
caspas
might
also
involv
altern
nonleth
function
suggest
yi
et
al
detect
apoptosi
use
caspas
enzym
remain
reliabl
wide
use
occurr
caspas
activ
cell
apoptosi
lead
cleavag
specif
substrat
later
easili
detect
marker
caspas
activ
inde
sever
antibodi
avail
use
myriad
caspas
substrat
includ
instanc
immunoblot
analysi
immunofluoresc
flow
cytometri
furthermor
detect
earli
apoptosi
may
possibl
thank
antibodi
detect
caspasecleav
form
substrat
protein
sitespecif
cleavag
altern
caspas
activ
assess
reagent
compat
ht
applic
exogen
proluminesc
fluorogen
caspas
substrat
realtim
assess
caspas
activ
may
allow
thank
substrat
bifunct
compound
fluoresc
biosensor
introduc
cell
therebi
studi
caspas
activ
remain
reliabl
specif
approach
assess
apoptosi
among
characterist
apoptosi
exposur
phospholipid
phosphatidylserin
ps
cell
membran
respons
proapoptot
stimuli
repres
major
featur
caspasedepend
process
healthi
cell
therefor
psbind
protein
annexinv
experiment
use
detect
ps
exposur
sever
annexinv
deriv
associ
differ
fluorochrom
use
apoptosi
measur
use
multicolor
flow
cytometri
fluoresc
microscopi
distinguish
apoptot
cell
nonapoptot
cell
annexinv
usual
combin
cellimperm
dye
propidium
iodid
apoptot
cell
annexinv
posit
intact
plasma
membran
remain
sensit
rapid
method
assess
apoptosi
must
keep
mind
ps
exposur
also
occur
cell
deathunrel
condit
especi
lymphocyt
activ
dna
fragment
apoptosi
caspasemedi
mechan
lead
specif
internucleosom
dna
doublestrand
break
fragment
multipl
base
pair
size
histor
gel
electrophoresi
genom
dna
use
demonstr
internucleosom
dna
fragment
apoptot
cell
display
characterist
dna
ladder
wherea
necrot
cell
show
smear
randomli
degrad
dna
supersed
faster
easier
method
matter
fact
determin
dna
content
number
apoptot
cell
preferenti
investig
use
flow
cytomet
dnabind
fluorochrom
propidium
iodid
detect
hypodiploid
nuclei
anoth
method
wide
use
studi
measur
dna
fragment
termin
dutp
nick
end
label
techniqu
base
format
endonucleasegener
dna
break
enzymat
label
termin
transferas
uridin
triphosph
deriv
coupl
fluorochrom
secondarili
immunoperoxidas
reaction
allow
detect
dna
fragment
evalu
quantit
fluoresc
microscopi
flow
cytometri
one
vigil
risk
falseposit
link
necrot
cell
method
pair
addit
assay
mitochondri
membran
depolar
mmd
occur
earli
apoptot
stage
primari
morpholog
biochem
alter
therefor
membran
potenti
monitor
provid
inform
kinet
apoptot
process
varieti
potentiometr
dye
flow
cytometri
fluoresc
microscopi
use
measur
mitochondri
membran
potenti
howev
hypothesi
mmd
earli
marker
mitochondri
alter
larg
controvert
decreas
transmembran
potenti
might
rather
consid
marker
mitochondri
damag
may
take
et
al
place
late
apoptosi
also
necrosi
beyond
mmd
momp
process
also
investig
releas
apoptogen
factor
includ
cytochrom
c
smac
endog
mitochondria
cytosol
final
apoptosi
initi
character
specif
morpholog
featur
must
keep
mind
microscop
analysi
cell
still
major
way
studi
apoptosi
instanc
microscop
analysi
chromatin
condens
dna
stain
autophagi
inhibitor
consid
potent
chemosensit
might
therefor
introduc
combin
regimen
optim
anticanc
therapi
method
measur
autophagi
includ
electron
microscopi
quantifi
autophagosom
immunoblot
detect
lipid
microtubulesassoci
protein
light
chain
also
known
immunofluoresc
microscopi
monitor
redistribut
diffus
pattern
punctat
one
complementari
techniqu
necessari
autophagosom
accumul
influenc
lysosom
acidif
instanc
anoth
way
assess
autophag
flux
thank
sever
method
pulsechas
immunoblot
luciferasebas
method
monitor
degrad
autophag
substrat
luciferas
coupl
recent
use
develop
realtim
htscompat
assay
monitor
autophag
flux
moreov
firefli
luciferas
shown
constitut
preferenti
autophag
substrat
henc
trust
marker
autophag
degrad
may
applic
ht
studi
addit
recent
develop
assay
allow
determin
phosphoryl
statu
substrat
critic
autophagi
regul
kinas
kinas
besid
sever
assay
recent
adapt
ht
final
method
use
identifi
underli
molecular
mechan
autophagi
quantifi
level
detect
necrosi
ferroptosi
immunogen
cell
death
one
best
method
studi
necrosi
use
morpholog
chang
occur
death
cell
thank
light
electron
microscopi
inde
term
necrosi
defin
mass
dead
cell
depend
specif
cell
death
pathway
specif
characterist
necrot
cell
describ
includ
nuclear
swell
chromatin
floccul
loss
nuclear
basophilia
breakdown
organel
function
cytolysi
swell
lead
membran
break
nonetheless
secondari
necrosi
repres
end
point
cell
death
modal
primari
necrosi
contrast
constitut
entir
cell
death
mechan
specif
characterist
difficult
identifi
specif
marker
necroptosi
biochem
process
character
necroptosi
also
take
place
apoptot
cell
death
best
way
detect
necroptosi
remain
analysi
crucial
kinas
activ
receptorinteract
protein
crossroad
death
signal
pathway
activ
measur
enzymat
assay
studi
phosphoryl
use
pharmacolog
inhibitor
inhibit
activ
may
use
identifi
necroptosi
anoth
commonli
use
assay
necrosi
detect
measur
extracellular
releas
highmobl
group
box
nonhiston
chromatinbind
protein
normal
regul
transcript
kit
avail
base
enzymelink
immunosorb
assay
test
quantif
recent
biomark
necrot
cell
also
describ
peptidylprolyl
isomeras
also
known
cyclophilin
cypa
seem
specif
releas
necroptot
cell
enzymelink
immunosorb
assay
kit
quantit
measur
cypa
also
commerci
avail
drug
bind
inhibit
cypa
explor
might
use
develop
cypaori
assay
besid
cypaori
assay
assay
adapt
ht
assay
detect
necrot
cell
death
present
data
concern
molecular
mechan
necroptosi
scarc
requir
research
concern
detect
ferroptosi
cell
undergo
form
cell
death
exhibit
specif
morpholog
featur
smaller
mitochondria
increas
densiti
easili
identifi
besid
occurr
ferroptosi
confirm
use
ferroptosi
inhibitor
final
regard
immunogen
cell
death
current
research
focus
develop
induc
vaccin
assay
immunodefici
mice
reconstitut
human
immun
system
simultan
detect
calr
exposur
atp
secret
releas
assess
cell
death
guidelin
detect
immunogen
cell
death
recent
publish
advantag
drawback
method
use
assess
cell
viabil
apoptosi
autophagi
necrosi
present
tabl
better
understand
cell
death
mechan
sine
qua
non
condit
improv
process
drug
discoveri
recent
review
rellovarona
et
al
claim
correct
evalu
cell
death
everi
experiment
set
relat
cancer
research
must
advoc
real
cell
death
character
understand
therapeut
failur
treatmentrel
side
effect
even
provid
suscept
marker
furthermor
crucial
assess
lead
chemotherapeut
approach
target
specif
cell
death
pathway
sever
novel
drug
current
test
journal
cell
death
clinic
mostli
phase
ii
trial
develop
new
drug
combin
understand
accur
effect
chemotherapi
death
signal
pathway
still
requir
cell
death
remain
central
basi
everi
therapeut
approach
regard
cancer
recent
specif
field
antisarcoma
therapi
assess
cell
death
mechan
publish
author
highlight
fact
sarcoma
research
need
implement
better
determin
cell
death
mechan
understand
chemoresist
cell
death
immunogen
potenti
sever
clinic
trial
evalu
target
therapi
sarcoma
regard
apoptosi
mitot
catastroph
still
ongo
concern
innov
concept
immunogen
cell
death
induct
form
death
nanocarrierbas
drug
deliveri
system
may
lead
potenti
therapi
pancreat
cancer
henc
need
possess
strong
cell
death
assay
explor
potenti
role
immunogen
cell
death
nanomedicin
understand
everi
molecular
signal
pathway
involv
cell
death
elabor
potenti
drug
could
interfer
specif
mechan
main
framework
progress
insight
cell
death
process
condit
sine
qua
non
develop
effect
specif
therapeut
approach
sever
vitro
method
assess
cell
death
exist
studi
larg
recommend
use
singl
method
quantit
qualit
data
cell
die
differ
mode
sometim
difficult
distinguish
therebi
essenti
measur
cell
death
involv
complementari
methodolog
inde
main
drawback
apoptosisspecif
necrosisspecif
assay
neither
assay
provid
unequivoc
inform
occurr
one
specif
cell
death
modal
compar
similarli
reliabl
method
detect
autophagi
yet
develop
anoth
import
point
concern
time
experiment
apoptosi
often
occur
quickli
wherea
necrosi
much
slower
thu
use
addit
clonogen
viabil
assay
necessari
correctli
assess
cell
death
pathway
final
progress
made
concern
cell
deathbas
ht
approach
lead
identif
promis
compound
combin
increasingli
sophist
microscop
method
acceler
discoveri
cell
death
modulatori
drug
